Raza Ali, Kopp Steven R, Jabbar Abdul, Kotze Andrew C
CSIRO Agriculture Flagship, Queensland Bioscience Precinct, University of Queensland, Brisbane, Australia; School of Veterinary Science, University of Queensland, Gatton, Australia.
School of Veterinary Science, University of Queensland, Gatton, Australia.
Vet Parasitol. 2015 Jun 30;211(1-2):80-8. doi: 10.1016/j.vetpar.2015.04.025. Epub 2015 May 8.
P-glycoproteins (P-gps) play an important role in the sensitivity of nematodes to anthelmintic drugs. They have been implicated in a number of anthelmintic resistances, particularly for macrocyclic lactone drugs. Hence, inhibition of nematode P-gps has been suggested as a means of reversing some types of anthelmintic resistance. The present study aimed to investigate the ability of the most-recently developed group of P-gp inhibitors (the so-called 'third generation' of inhibitors) including tariquidar, zosuquidar and elacridar, to increase the sensitivity of Haemonchus contortus larvae to various anthelmintics (ivermectin, levamisole and thiabendazole) in vitro. We compared these compounds to some older P-gp inhibitors (e.g. verapamil and valspodar). Larval migration and development assays were used to measure the sensitivity of larvae to anthelmintics alone, or in combination with P-gp inhibitors. Significant increases in sensitivity to ivermectin were observed with zosuquidar and tariquidar in larval migration assays (synergism ratios up to 6-fold). Several of the inhibitors increased the sensitivity of both the drug-resistant and -susceptible isolates (e.g. tariquidar with ivermectin in migration assays, zosuquidar with ivermectin in larval development assays), while others had significant effects on the resistant isolate only (e.g. zosuquidar with ivermectin in migration assays, verapamil with ivermectin in development assays). This suggests that some of the inhibitors interact with P-gps representing intrinsic pathways present across nematode populations with quite different drug sensitivities, while other inhibitors interact with P-gps of significance only to resistant nematodes, and hence most likely representing an acquired resistance mechanism. The study highlights the potential of the third generation of P-gp inhibitors for increasing the sensitivity of nematodes to anthelmintics.
P-糖蛋白(P-gps)在 nematodes 对驱虫药物的敏感性中起重要作用。它们与多种驱虫抗性有关,特别是对大环内酯类药物。因此,抑制线虫P-gps已被建议作为逆转某些类型驱虫抗性的一种手段。本研究旨在调查最新开发的一组P-gp抑制剂(即所谓的“第三代”抑制剂),包括 tariquidar、zosuquidar 和 elacridar,在体外增加捻转血矛线虫幼虫对各种驱虫药(伊维菌素、左旋咪唑和噻苯达唑)敏感性的能力。我们将这些化合物与一些较老的P-gp抑制剂(如维拉帕米和valspodar)进行了比较。幼虫迁移和发育试验用于测量幼虫单独对驱虫药或与P-gp抑制剂联合使用时的敏感性。在幼虫迁移试验中,zosuquidar和tariquidar使对伊维菌素的敏感性显著增加(协同比高达6倍)。几种抑制剂增加了耐药和敏感分离株的敏感性(如迁移试验中tariquidar与伊维菌素联合、幼虫发育试验中zosuquidar与伊维菌素联合),而其他抑制剂仅对耐药分离株有显著影响(如迁移试验中zosuquidar与伊维菌素联合、发育试验中维拉帕米与伊维菌素联合)。这表明一些抑制剂与代表线虫群体中存在的固有途径的P-gps相互作用,这些线虫群体具有相当不同的药物敏感性,而其他抑制剂仅与耐药线虫的P-gps相互作用,因此很可能代表一种获得性抗性机制。该研究突出了第三代P-gp抑制剂在增加线虫对驱虫药敏感性方面的潜力。